effect
control
potenti
outbreak
middl
east
respiratori
syndrom
mer
highli
sensit
specif
laboratori
diagnost
test
need
nucleic
acid
amplif
assay
method
wide
use
provid
laboratori
confirm
mer
mer
case
routin
confirm
base
detect
uniqu
mer
coronaviru
merscov
rna
sequenc
realtim
reversetranscript
rrt
pcr
confirm
nucleic
acid
sequenc
necessari
recent
publish
updat
interim
recommend
merscov
laboratori
test
recommend
rrtpcr
assay
target
envelop
upe
gene
screen
follow
confirm
assay
region
encod
either
open
read
frame
orf
nucleocapsid
protein
n
sequenc
two
target
site
merscov
genom
rnadepend
rna
polymeras
rdrp
n
gene
suggest
although
commerci
rrtpcr
assay
merscov
detect
develop
sever
manufactur
includ
altona
diagnost
fast
track
diagnost
primerdesign
ltd
studi
valid
diagnost
perform
use
authent
specimen
lack
evalu
analyt
perform
clinic
applic
powerchek
mer
upe
realtim
pcr
kit
powerchek
mer
assay
kogen
biotech
seoul
korea
powerchek
mer
assay
recent
develop
onestep
rrtpcr
assay
qualit
detect
merscovspecif
rna
receiv
conform
europein
vitro
diagnost
ceivd
ministri
food
drug
safeti
mfd
korea
approv
probe
specif
upe
intern
control
region
label
carboxyfluorescein
fam
joe
indodicarbocyanin
fluorophor
respect
assay
previous
evalu
small
number
clinic
specimen
report
present
result
perform
evalu
powerchek
mer
assay
use
clinic
respiratori
specimen
institut
review
board
samsung
medic
center
seoul
korea
approv
studi
analysi
clinic
respiratori
specimen
sputa
nasopharyng
swab
collect
differ
individu
june
juli
fifti
specimen
obtain
symptomat
mersposit
patient
remain
obtain
asymptomat
mersneg
healthcar
worker
activ
monitor
total
nucleic
acid
extract
use
qiaamp
dsp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
total
specimen
use
rna
elut
store
test
powerchek
mer
sequenc
assay
merscov
rna
detect
use
powerchek
mer
assay
amplif
upe
primer
probe
use
accord
previou
studi
rrtpcr
reaction
perform
use
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
pcr
reaction
perform
total
volum
pcr
reaction
mixtur
templat
rna
thermocycl
condit
follow
min
follow
min
cycl
sec
sec
viral
control
notempl
control
includ
run
dehydrogenas
gapdh
gene
amplifi
simultan
heterolog
endogen
intern
control
monitor
pcr
inhibit
specimen
qualiti
posit
test
result
defin
welldefin
exponenti
fluoresc
curv
cross
threshold
cycl
cycl
cycl
upe
gapdh
gene
respect
nest
rtpcr
sequenc
target
rdrp
n
gene
perform
confirm
accord
previou
protocol
briefli
first
round
rtpcr
two
gene
perform
use
primer
set
describ
previou
report
second
round
conduct
product
visibl
agaros
gel
electrophoresi
first
round
pcr
product
sequenc
use
dna
analyz
appli
biosystem
merscov
rna
transcript
synthes
vitro
promot
previous
report
use
analyt
perform
evalu
limit
detect
lod
point
replic
given
viral
load
detect
determin
use
vitro
rna
transcript
dilut
nucleasefre
water
serial
dilut
analyz
replic
per
dilut
probit
analysi
use
determin
lod
reproduc
repeat
lottolot
precis
determin
use
three
concentr
reproduc
calcul
test
duplic
concentr
singl
run
five
day
two
differ
test
site
repeat
calcul
test
duplic
concentr
singl
run
day
lottolot
precis
access
test
duplic
concentr
singl
run
five
day
use
three
differ
lot
assay
specif
evalu
nucleic
acid
obtain
divers
collect
respiratori
virusposit
clinic
specimen
respiratori
bacteri
isol
refer
strain
one
clinic
isol
tabl
diagnost
perform
powerchek
mer
assay
rdrp
n
gene
sequenc
assay
compar
measur
posit
percent
agreement
ppa
neg
percent
agreement
npa
valu
kappa
coeffici
rdrp
n
gene
sequenc
assay
consid
refer
standard
method
diagnost
sensit
specif
powerchek
mer
assay
calcul
statist
analys
perform
use
vassarstat
websit
http
vassarstatsnet
spss
softwar
version
spss
inc
chicago
il
usa
p
valu
consid
statist
signific
tabl
show
analyt
sensit
powerchek
mer
assay
lod
upe
region
copiesreact
copiesreact
respect
tabl
show
precis
result
powerchek
mer
assay
reproduc
studi
cv
rang
assay
show
accept
repeat
cv
result
rang
lottolot
variat
accept
low
concentr
cv
rang
falseposit
test
result
obtain
viral
bacteri
isol
posit
control
readili
detect
tabl
comparison
result
powerchek
mer
rdrp
n
gene
sequenc
assay
shown
tabl
method
gave
posit
result
clinic
specimen
obtain
symptomat
mersposit
patient
specimen
powerchek
mer
assay
yield
posit
reaction
upe
target
rang
ct
valu
upe
gapdh
target
respect
method
gave
neg
result
specimen
obtain
asymptomat
mersneg
individu
two
assay
produc
concord
result
specimen
kappa
valu
diagnost
sensit
specif
powerchek
mer
assay
confid
interv
date
variou
report
publish
efficaci
rrtpcr
assay
detect
merscovspecif
rna
target
variou
region
includ
upe
n
gene
interim
recommend
publish
suggest
upe
assay
use
screen
follow
confirm
one
n
gene
assay
similarli
us
center
diseas
control
prevent
cdc
develop
use
rrtpcr
assay
compos
two
independ
pcr
reaction
one
assay
combin
upe
test
screen
second
assay
confirm
posit
result
previou
evalu
rrtpcr
assay
use
mock
specimen
spike
cultur
merscov
small
number
clinic
specimen
mersinfect
patient
studi
use
total
authent
clinic
specimen
mersposit
patient
variou
viral
load
powerchek
mer
assay
could
prevent
misjudg
sampl
error
sinc
use
endogen
intern
control
use
endogen
intern
control
would
help
artifici
target
sinc
endogen
intern
control
enabl
monitor
rna
extract
revers
transcript
step
specimen
qualiti
well
monitor
specimen
qualiti
import
assay
perform
detect
merscov
depend
specimen
qualiti
powerchek
mer
assay
simpl
effici
reduc
workload
requir
diagnosi
rrtpcr
assay
requir
mix
premix
rna
reduc
handson
time
risk
technic
error
turnaround
time
rna
extract
final
result
hr
rapid
simpl
test
techniqu
would
especi
use
manag
larg
mer
outbreak
studi
sever
limit
first
powerchek
mer
assay
valid
upper
lower
respiratori
specimen
furthermor
clinic
specimen
mersconfirm
patient
sputum
specimen
although
lower
respiratori
specimen
prefer
specimen
type
initi
mer
diagnosi
higher
merscov
load
rrtpcr
test
use
specimen
type
includ
serum
urin
stool
specimen
requir
mersconfirm
case
thu
studi
evalu
perform
use
specimen
type
need
second
compar
assay
perform
across
differ
realtim
pcr
platform
powerchek
mer
assay
develop
allow
flexibl
choic
realtim
pcr
platform
use
fast
realtim
pcr
system
realtim
pcr
detect
system
biorad
hercul
ca
usa
lightcycl
roch
mannheim
germani
rotorgen
q
qiagen
hilden
germani
thermocycl
agil
technolog
ca
usa
howev
evalu
perform
use
fast
realtim
pcr
system
conclus
powerchek
mer
assay
good
diagnost
perform
detect
merscov
rna
straightforward
accur
assay
use
tool
rapid
diagnosi
mer
could
especi
import
control
mer
outbreak
